Gilead signs licensing deals for HIV treatment

09-10-2017

Gilead signs licensing deals for HIV treatment

ktsimage / iStockphoto.com

Gilead Sciences has signed licensing agreements with the Medicines Patent Pool (MPP) and generic companies to provide greater access to HIV treatment bictegravir.


Gilead, Medicines Patent Pool, Mylan, Sun Pharmaceutical, patent, patent licensing, HIV treatment

LSIPR